- Title
- 27851 Efficacy of guselkumab (GUS) on axial-related endpoints in patients with active psoriatic arthritis (PsA) with imaging-confirmed sacroiliitis: Results through week 52 from DISCOVER-1 and DISCOVER-2
- Creators
- Alice B. Gottlieb - Icahn School of Medicine at Mount SinaiJoseph F. Merola - Brigham and Women's HospitalApril W. Armstrong - University of Southern CaliforniaLaura Savage - NIHR Leeds Musculoskeletal Biomedical Research UnitSoumya D. Chakravarty - Drexel UniversityAlexa P. Kollmeier - JanssenBei Zhou - JanssenYa-Wen Yang - Janssen Global Services, LLCKristen Sweet - JanssenWolf-Henning Boehncke - Geneva University Hospitals
- Publication Details
- Journal of the American Academy of Dermatology, v 85(3), pp AB39-AB39
- Publisher
- Elsevier
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- Rheumatology; General Internal Medicine
- Other Identifier
- 991021930319704721
Abstract
27851 Efficacy of guselkumab (GUS) on axial-related endpoints in patients with active psoriatic arthritis (PsA) with imaging-confirmed sacroiliitis: Results through week 52 from DISCOVER-1 and DISCOVER-2
Journal of the American Academy of Dermatology, v 85(3), pp AB39-AB39
Sep 2021
Metrics
7 Record Views